| Deepthi Chandra Malepati, MD | |
|
717 Delaware Street Se, Mail Code 1932j, Minneapolis, MN 55414 | |
| (612) 624-9444 | |
| Not Available |
| Full Name | Deepthi Chandra Malepati |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 717 Delaware Street Se, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841652146 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
News Archive
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.
InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus' Dynamic Cross Linking (DXL™) antibodies using XERIS' proprietary formulation-injection technologies.
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called DNA methylation that occurs before birth may be a root cause.
› Verified 6 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.
InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus' Dynamic Cross Linking (DXL™) antibodies using XERIS' proprietary formulation-injection technologies.
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called DNA methylation that occurs before birth may be a root cause.
› Verified 6 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.
InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus' Dynamic Cross Linking (DXL™) antibodies using XERIS' proprietary formulation-injection technologies.
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called DNA methylation that occurs before birth may be a root cause.
› Verified 6 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.
InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus' Dynamic Cross Linking (DXL™) antibodies using XERIS' proprietary formulation-injection technologies.
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called DNA methylation that occurs before birth may be a root cause.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deepthi Chandra Malepati, MD 717 Delaware St Se, Minneapolis, MN 55414-2959 Ph: (651) 770-9451 | Deepthi Chandra Malepati, MD 717 Delaware Street Se, Mail Code 1932j, Minneapolis, MN 55414 Ph: (612) 624-9444 |
News Archive
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
President Obama's "budget request demonstrates a strong and well-timed endorsement of the Global Fund [to Fight AIDS, Tuberculosis and Malaria] in advance of the replenishment, and will hopefully leverage similarly strong pledges from other donors," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development, and Jenny Ottenhoff, policy outreach associate at the center, write in the CGD's "Global Health Policy" blog.
InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus' Dynamic Cross Linking (DXL™) antibodies using XERIS' proprietary formulation-injection technologies.
Children whose mothers or grandmothers smoked during pregnancy are at increased risk of asthma in childhood, but the underlying causes of this are not well understood. Now a new study indicates changes in a process called DNA methylation that occurs before birth may be a root cause.
› Verified 6 days ago
Pascal Frino, M.D Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1 Veterans Dr, Minneapolis, MN 55417 Phone: 612-467-3183 | |
Dr. Ronald Alexander Reilkoff, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Eugenia Shmidt, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 507-284-2511 | |
Daniel Tesfaye Kebed, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 Fax: 612-273-4098 | |
Tenzin Yangchen, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2925 Chicago Ave, Minneapolis, MN 55407 Phone: 612-863-4000 Fax: 763-236-3026 | |
Shelley M Lennox, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 920 E 28th St, Suite 700, Minneapolis, MN 55407 Phone: 612-863-9062 Fax: 612-863-9252 | |
Dr. Markus Meyer, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2450 Riverside Ave, Minneapolis, MN 55454 Phone: 612-672-6000 |